Prince Joshua S.
SEC insider (Form 3/4/5 filer). CIK 0001998663. Chief Operating Officer at Vistagen Therapeutics, Inc. (VTGN). 6 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Prince Joshua S. has filed insider reports for
- Vistagen Therapeutics, Inc. (VTGN): Officer, Chief Operating Officer
Prince Joshua S.
CIK: 0001998663
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Vistagen Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Apr 7, 2026VTGN
Vistagen Therapeutics, Inc.
AwardDirectIncentive Stock Option (right to buy)
18.8K shares- - Apr 7, 2026VTGN
Vistagen Therapeutics, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
56.2K shares- - Dec 31, 2025VTGN
Vistagen Therapeutics, Inc.
AwardDirect4.4K shares at avg. $0.56$2K - Jun 30, 2025VTGN
Vistagen Therapeutics, Inc.
AwardDirect4.9K shares at avg. $1.70$8K - Jun 23, 2025VTGN
Vistagen Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
100K shares- - Dec 31, 2024VTGN
Vistagen Therapeutics, Inc.
AwardDirect3.3K shares at avg. $2.51$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 7, 2026 | VTGN Vistagen Therapeutics, Inc. | Award Incentive Stock Option (right to buy) | 18,752 | - | - | Direct |
| Apr 7, 2026 | VTGN Vistagen Therapeutics, Inc. | Award Non-Qualified Stock Option (right to buy) | 56,248 | - | - | Direct |
| Dec 31, 2025 | VTGN Vistagen Therapeutics, Inc. | Award | 4,386 | $0.56 | $2,468 | Direct |
| Jun 30, 2025 | VTGN Vistagen Therapeutics, Inc. | Award | 4,882 | $1.70 | $8,299 | Direct |
| Jun 23, 2025 | VTGN Vistagen Therapeutics, Inc. | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| Dec 31, 2024 | VTGN Vistagen Therapeutics, Inc. | Award | 3,310 | $2.51 | $8,300 | Direct |
1-6 of 6 transactions